Event Type: Earnings Conference Call to discuss financial results for the fourth quarter and year ended March 31, 2026.

Date and Time: The call was hosted on May 25, 2026. Specific time and time zone were not mentioned in the disclosure.

Purpose: Discussion of operational and financial performance for Q4 FY26 and full year FY26.

Management Participants:

  • Mr. Himanshu Zota – Founder and Whole Time Director
  • Mr. Moxesh Zota – Managing Director
  • Dr. Sujit Paul – Group Chief Executive Officer
  • Mr. Ajit Mishra – Ernst & Young Investor Relations (Moderator)

Availability of Materials: The transcript of the earnings conference call is available on the company website at https://www.zotahealthcare.com/wp-content/uploads/2026/05/Q4FY26-FY26-Earnings-Call-Transcript.pdf. The press release and presentation were also mailed to participants and available on exchanges and company website.

Financial Period Discussed: Q4 FY26 and full year FY26 (year ended March 31, 2026).

Key Financial Highlights from Call:

  • Consolidated revenue from operations for FY26: INR 53,865 lakhs (83.86% YoY growth)
  • Davaindia sales: INR 41,741 lakhs (nearly doubled from previous year)
  • Domestic formulations: INR 6,794 lakhs
  • Export sales: INR 3,471 lakhs
  • Everyday Herbal business: INR 1,846 lakhs
  • Gross profit: INR 32,468 lakhs (108% YoY growth)
  • Gross margin: 60.28% (714 basis points expansion)
  • EBITDA: INR 2,597 lakhs (positive vs negative in FY25)
  • EBITDA margin: 4.82% for full year
  • Q4 EBITDA: INR 1,191 lakhs with 7.3% margin

Operational Highlights:

  • Added 997 new Davaindia stores in FY26 (804 COCO, 193 FOFO)
  • Total network: 2,579 stores nationwide (1,656 COCO, 923 FOFO)
  • Davaindia contributed 77% of overall revenue
  • Annual footfalls: over 182 lakh customers (nearly doubled YoY)
  • GMV: INR 45,706 lakhs
  • Same-store growth (SSG): Over 40% for stores operational as of March 2025
  • Stores 24+ months: 35-40% SSG
  • Stores 12-24 months: 55-60% SSG

Strategic Initiatives:

  • Completed INR 350 crores QIP
  • Increased stake in Everyday Herbal Beauty Care Limited to 87.78%
  • Brand associations with Mr. Suniel Shetty and Mr. MS Dhoni
  • Plans for UGO Generic platform and All Day Stores

Forward-looking Statements:

  • Focus on improving store-level profitability and operational efficiency for next 1-2 quarters
  • Moderate pace of expansion initially, ramping up in Q3-Q4 FY27
  • Target of 500-700 new store additions in FY27
  • Long-term vision of scaling 5,000+ Davaindia stores by FY29
  • Mature stores (2-3 years old) showing average wallet spend of INR 270-290
  • Store maturation typically within 3-5 year range achieving INR 6-7 lakh monthly sales

Compliance Statement: The document contains standard forward-looking statement disclaimer about known and unknown risks and uncertainties.

Additional Notes Section

The disclosure includes the full transcript of the earnings conference call containing detailed financial and operational discussions. No attachments were mentioned beyond the transcript itself. The announcement primarily serves to inform about the availability of the earnings call transcript rather than disclosing new financial data.